Subtotal $0.00
Shop Now
Stopping Ozempic or a related medicine usually means regaining a large part of the weight that was lost. In the STEP 1 extension, people who stopped weight-management semaglutide regained about two-thirds of their lost weight within a year, and improvements in blood pressure, blood sugar and cholesterol drifted back toward where they started. In the SURMOUNT-4 trial, people switched from tirzepatide to placebo regained 14% of their body weight over a year, while those who continued lost a little more. Regain is gradual, because semaglutide stays in the body for about five weeks after the last injection, and on average weight had not returned fully to its starting point after a year. Never stop without a plan from your prescriber, especially if you have type 2 diabetes.
Peptide Labs does not sell Ozempic, Wegovy, Mounjaro, Zepbound or any prescription drug. This article summarizes FDA labels and published trials. It does not give instructions on missed injections, restarting or tapering; those belong to your prescriber and the medicine’s label.
Key Takeaways
- STEP 1 extension: one year after stopping semaglutide, people had regained 11.6 of the 17.3 percentage points they had lost.
- SURMOUNT-4: switching from tirzepatide to placebo led to 14% weight regain over 52 weeks.
- Health markers improved on the medicine and moved back toward baseline after stopping.
- Semaglutide stays in circulation about five weeks after the last injection, so effects fade over weeks.
- Regain happened even with standard diet counseling; better lifestyle programs have not been tested.
- Talk to your prescriber before stopping, especially if the medicine manages diabetes.
What happens when you stop Ozempic?
What happens when you stop Ozempic depends partly on how long the medicine lingers. The Ozempic label (revised May 2026) gives semaglutide an elimination half-life of about one week and says it remains in the circulation for about five weeks after the last injection. Tirzepatide, in Mounjaro and Zepbound, has a half-life of about five days. The effects therefore fade over several weeks rather than overnight.
These medicines lower body weight mainly by reducing appetite and food intake. As levels fall, hunger and interest in food tend to return toward their earlier pattern; our guide to the hormones that drive hunger and fullness explains the systems involved. Digestive effects such as nausea and slower stomach emptying are drug effects too, so they would be expected to ease as the medicine clears, although no label gives a timeline.
For people with type 2 diabetes, Ozempic is part of what keeps blood sugar in range. In the STEP 1 extension, which enrolled people without diabetes, blood sugar measures that improved on semaglutide moved back toward baseline after stopping. Anyone using it for diabetes needs a plan for glucose monitoring and, often, another medicine.
Ozempic weight regain: what the withdrawal trials found
Three trials tested Ozempic weight regain directly by stopping the medicine or swapping it for placebo. All three used the weight-management versions (Wegovy-strength semaglutide or Zepbound), not Ozempic itself, and all were run by the drugmakers.
| Trial | Design | What happened after stopping | Sponsor |
|---|---|---|---|
| STEP 1 extension (semaglutide) | 327 adults without diabetes; medicine and lifestyle program stopped at week 68, then followed for one more year | Regained 11.6 of 17.3 points lost; still 5.6% below starting weight on average | Novo Nordisk |
| STEP 4 (semaglutide, Wegovy label Study 5) | 803 adults; 20 weeks on the medicine, then randomized to continue or switch to placebo for 48 weeks | Placebo group gained 6.9% of body weight; continuing group lost a further 7.9% | Novo Nordisk |
| SURMOUNT-4 (tirzepatide, Zepbound label Study 4) | 670 adults; 36 weeks on the medicine (20.9% average loss), then randomized for 52 weeks | Placebo group regained 14.0%; continuing group lost a further 5.5% | Eli Lilly |
In SURMOUNT-4, 89.5% of people who kept taking tirzepatide held on to at least 80% of their earlier weight loss, compared with 16.6% of those switched to placebo. Even so, the placebo group was still 9.9% below its starting weight at the end of the trial. The Wegovy label adds a caution about STEP 4: only people who tolerated the first 20 weeks were randomized, so results may not reflect everyone who starts the medicine.
Is there an Ozempic rebound?
The idea of an Ozempic rebound, where weight shoots back up past where it started, is not what the average results showed. Regain in the trials was steady rather than sudden, and after a year off semaglutide the typical participant was still about 5.6% lighter than at the start. Averages hide wide individual differences, though, and some people regain more than others.
Health markers followed the weight. The STEP 1 extension reported that improvements in measures such as blood pressure, blood sugar and blood fats seen on semaglutide moved back toward baseline for most variables after stopping. The authors concluded that the findings confirm obesity is a chronic condition and suggest ongoing therapy is needed to keep the benefits.
Why the weight comes back
Several forces push weight back up once the medicine wears off:
- Appetite returns. The medicine’s appetite-lowering effect fades as it leaves the body.
- A smaller body needs less energy. Lower body weight means fewer calories burned, one reason weight loss slows and regain is easy; see why weight loss stalls.
- Standard counseling was not enough. The 2025 joint nutrition advisory notes that regain was seen even when participants had received conventional diet counseling or behavioral therapy.
- Lifestyle changes stopped too. In the STEP 1 extension, the trial’s lifestyle program ended at the same time as the medicine.
The advisory also flags a muscle concern: in the absence of structured nutrition and exercise, muscle and bone loss may be made worse by stopping and restarting GLP-1 medicines and the weight cycling that follows. Our article on muscle loss on GLP-1 medicines covers what the body-scan data show.
Why people stop GLP-1 medicines
Stopping is common. The advisory cites real-world data showing that only about a third to a half of people prescribed a GLP-1 for weight are still taking it after one year, and about 15% after two years. Stopping has been linked with age 65 and older, a weaker weight response and moderate or severe digestive side effects. Insurance changes and shortages may also play a part.
Some reasons to stop come from the labels themselves. The Medication Guides tell people to stop and call for help if they have signs of pancreatitis or a serious allergic reaction, and the semaglutide labels advise stopping at least two months before a planned pregnancy. In each case the prescriber should be part of the decision.
Before stopping Ozempic: questions for your prescriber
- If I have diabetes, what replaces this medicine, and how should I monitor my blood sugar?
- Is stopping, switching or continuing the right choice for my health goals?
- Should my other medicines change when I stop, for example insulin or blood pressure medicines?
- What should I do about missed injections or restarting after a break? (The answer depends on the label and how long it has been, so ask rather than guess.)
- Can I get support from a registered dietitian or exercise program as I come off the medicine?
Habits that may help after stopping
No controlled trial has tested a structured program for preventing regain after a GLP-1 medicine, so these points are reasonable steps rather than proven fixes. The advisory recommends regular strength training, protein-focused regular meals and attention to sleep and stress during and after therapy; our eating guide for GLP-1 medicines has practical meal ideas. Weighing yourself regularly and agreeing with your prescriber on a point at which to check in can catch regain early. To see what results look like while people stay on these medicines, read typical results in GLP-1 trials; for how quickly they act when started, see how long Ozempic takes to work.
Frequently Asked Questions
What happens when you stop taking Ozempic?
The medicine leaves the body over about five weeks, appetite tends to return and, in trials, weight gradually came back. Blood sugar can rise in people who use it for diabetes.
How much weight do people regain after stopping semaglutide?
In the STEP 1 extension, people regained about two-thirds of the weight they had lost within a year of stopping, ending about 5.6% below their starting weight on average.
Is Ozempic weight regain the same with tirzepatide?
Similar. In SURMOUNT-4, people switched from tirzepatide to placebo regained 14% of body weight over a year, while those who continued lost a further 5.5%.
Is there an Ozempic rebound above my starting weight?
Not on average. Trial participants regained gradually and were still below their starting weight a year later, though individual results varied.
Can I stop Ozempic on my own?
Talk to your prescriber first. If it manages diabetes, stopping can raise blood sugar, and other medicines may need changes. Instructions on missed injections come from the prescriber and label.
Can diet and exercise prevent regain after stopping?
They may help, but no controlled trial has tested a structured program for this. Experts recommend strength training, protein-focused meals and regular check-ins.
Peptide Labs does not sell GLP-1 medicines or any prescription drug. This article is general information, not medical advice. Read the Medication Guide that comes with a prescription, and ask a pharmacist or prescriber how this information applies to you.
Last reviewed October 2026.
Related guides: GLP-1 for Weight Loss: What the Trials Actually Showed, Weight Loss Plateau: Why It Happens and What the Evidence Says Helps, Hunger Hormones: How Ghrelin, Leptin and Satiety Signals Work.